IL7 and neoplasm: In conclusion, our study illustrates that providing tumor-localized IL-7 cytokine support via T cells engineered to secrete as well as utilize the cytokine in a dual-antigen targeting binary system enhances the expansion and anti-tumor function of CAR T cells.